Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

An AI teaching platform for medical students learning about lupus nephritis

Compares an AI teaching platform with slides for teaching lupus nephritis to medical students.

Plain-language title generated from the registry record
Registry title: Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis

Key facts

Where
Nanjing, ChinaSee the site

Where in China

  • Nanjing UniversityNanjing, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Nanjing University
Trial code
NCT07706998
Record updated
16 July 2026
Original description
Aim:Read full original descriptionShow less

Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis

Aim:

To evaluate the application effect of the teaching platform iLN in the teaching of lupus nephritis, aiming to provide practical experience and evidence-based support for the implementation of generative AI technology in professional medical education.

Method:

Based on the DeepSeek large language model, the investigators developed "iLN" - an interactive teaching platform for lupus nephritis. This platform integrates the latest authoritative textbooks, clinical guidelines, pathological atlases, and real clinical cases, and includes seven core modules, such as "case interaction", "knowledge teaching", and "AI question answering". The investigators conducted a randomized controlled trial (RCT) on 50 fourth-year undergraduate students from Nanjing University School of Medicine to evaluate the effectiveness of the iLN platform compared to traditional teaching methods. The teaching effect was evaluated through objective test scores and questionnaires about student satisfaction and platform usability.

Inclusion: As a student majoring in clinical medicine; Volunteering to participate in the study.

Exclusion: Failure to participate in any stage of the study (e.g. in-class education session, or post-test); Inability to understand, read, or communicate in Chinese; Requesting withdrawal from the study.

ClinicalTrials.gov NCT07706998